Sarina Piha-Paul, MD
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sarina Piha-Paul, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:33 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03435952 · Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NTM.D. Anderson Cancer Center · completed · Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs, Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System · principal investigator
- Ph1NCT01582191 · Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic CancerM.D. Anderson Cancer Center · completed · Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm · principal investigator
- Ph1NCT01548144 · Pazopanib or Pemetrexed and Crizotinib in Advanced CancerM.D. Anderson Cancer Center · terminated · Advanced Cancers · principal investigator
- Ph1NCT01143779 · FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and BortezomibM.D. Anderson Cancer Center · completed · Advanced Cancer · principal investigator
- Ph1NCT00610493 · Bevacizumab and Temsirolimus in Patients With Advanced MalignancyM.D. Anderson Cancer Center · completed · Advanced Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.